STRONGYLOIDES IgG VIRCLIA® MONOTEST

STRONGYLOIDES IgG VIRCLIA® MONOTEST

Immunoassay Tests
STRONGYLOIDES IgG VIRCLIA® MONOTEST
STRONGYLOIDES IgG VIRCLIA® MONOTEST

Information

The first CLIA test for the detection of IgG antibodies against Strongyloides stercoralis in human serum/plasma offering random access and continuous loading. Say goodbye to sending off or accumulating samples and get same-day results with assurance. > Excellent sensitivity (94%) and specificity (93%) > Adapted to urgent diagnosis - Rapid, automated protocol, results in around 1h > No sample cumulation compared to the only existing ELISA’s in the market > Full compatibility with the VirClia portfolio +90 assays
Vircell, S.L.S1.K19Founded in 1991, Vircell is a biotechnology company specialized in the development and production of ready-to-use reagents for the diagnosis of infectious diseases in humans by different techniques – ranging from the traditional cell culture to the most innovating developments in the field of molecular biology. Vircell has been a successful market player worldwide distributing its products in over 95 countries in the five continents. The in-house production of all the antigens needed for the development of its kits enables Vircell to work with independence from external suppliers. This peculiarity makes it a flexible company able to guarantee the quality of its products. The reliability of its kits is the result of a strict quality control according to international standards. All distributed tests are validated and CE-marked complying with the European directive 98/79/CE. Vircell is certified ISO 13485:2003 and ISO 9001:2000 and is involved in the process of implementation of GMP standards.

Log in

See all the content and easy-to-use features by logging in or registering!